reserpine has been researched along with Depression, Endogenous in 75 studies
Reserpine: An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use.
reserpine : An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic pain has consistently been correlated with depression." | 5.43 | Echinocystic acid reduces reserpine-induced pain/depression dyad in mice. ( Deng, YT; Feng, B; Han, J; Li, S; Wang, DS; Wang, XS; Yang, Q; Zhao, MG, 2016) |
| " Animals were induced to a reserpine-induced depression model and were then chronically treated with duloxetine, desvenlafaxine or vehicle." | 3.85 | A standardization of the Novelty-Suppressed Feeding Test protocol in rats. ( Blasco-Serra, A; Cervera-Ferri, A; González-Soler, EM; Teruel-Martí, V; Valverde-Navarro, AA, 2017) |
| "If atenolol was contraindicated, 0." | 2.67 | Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. ( Applegate, WB; Camel, GH; Greenlick, MR; Hadley, E; Luhr, J; Moye, L; Perry, HM; Pressel, S; Shekelle, RB; Wittes, J, 1994) |
| "The development of efficient models for psychiatric diseases is complicated since the mechanisms of the disorders are not clear, major parts of the diagnosis depend on verbal communication with the patient and many of the symptoms are expressed mainly through the subjective experiences of the afflicted individual." | 2.41 | [Animal models of psychiatric diseases: possibilities, limitations, examples and demonstration of use]. ( Belmaker, RH; Einat, H, 2001) |
| "Nomifensine has demonstrated efficacy in several animal models that have been found to be predictive of clinical antidepressant activity, and has also been found to have a low potential for both cardiovascular and anticholinergic side effects." | 2.37 | Pharmacology of nomifensine: a review of animal studies. ( Fielding, S; Szewczak, MR, 1984) |
| "Chronic pain and depressive disorders have been estimated to co-occur in up to 80% of patients and traditional antidepressants and analgesics have shown limited clinical efficacy." | 1.48 | α- (phenylselanyl) acetophenone mitigates reserpine-induced pain-depression dyad: Behavioral, biochemical and molecular docking evidences. ( Alves, D; Balaguez, R; Baldinotti, R; Birmann, PT; Brüning, CA; Fronza, MG; Savegnago, L; Sousa, FSS, 2018) |
| "Chronic pain has consistently been correlated with depression." | 1.43 | Echinocystic acid reduces reserpine-induced pain/depression dyad in mice. ( Deng, YT; Feng, B; Han, J; Li, S; Wang, DS; Wang, XS; Yang, Q; Zhao, MG, 2016) |
| "Fibromyalgia is a prevalent and burdensome disorder characterized by chronic widespread pain and complex comorbid symptoms." | 1.35 | Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia. ( Aoki, T; Matsuoka, N; Nagakura, Y; Oe, T, 2009) |
| "Treatment with reserpine and discontinuance of antipsychotic drugs was useful for patients with severe symptoms of tardive dyskinesia or akathisia; complete remission with elimination of all drugs was achieved in 4 of 19 treated patients, without recurrence of symptoms." | 1.27 | A therapeutic approach to tardive dyskinesia. ( Fahn, S, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 59 (78.67) | 18.7374 |
| 1990's | 5 (6.67) | 18.2507 |
| 2000's | 5 (6.67) | 29.6817 |
| 2010's | 6 (8.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blasco-Serra, A | 1 |
| González-Soler, EM | 1 |
| Cervera-Ferri, A | 1 |
| Teruel-Martí, V | 1 |
| Valverde-Navarro, AA | 1 |
| Sousa, FSS | 1 |
| Birmann, PT | 1 |
| Baldinotti, R | 1 |
| Fronza, MG | 1 |
| Balaguez, R | 1 |
| Alves, D | 1 |
| Brüning, CA | 1 |
| Savegnago, L | 1 |
| Park, BK | 1 |
| Kim, YR | 1 |
| Kim, YH | 1 |
| Yang, C | 1 |
| Seo, CS | 1 |
| Jung, IC | 1 |
| Jang, IS | 1 |
| Kim, SH | 1 |
| Lee, MY | 1 |
| Antkiewicz-Michaluk, L | 1 |
| Wąsik, A | 1 |
| Możdżeń, E | 1 |
| Romańska, I | 1 |
| Michaluk, J | 1 |
| Minor, TR | 1 |
| Hanff, TC | 1 |
| Li, S | 1 |
| Han, J | 1 |
| Wang, DS | 1 |
| Feng, B | 1 |
| Deng, YT | 1 |
| Wang, XS | 1 |
| Yang, Q | 1 |
| Zhao, MG | 1 |
| Nagakura, Y | 1 |
| Oe, T | 1 |
| Aoki, T | 1 |
| Matsuoka, N | 1 |
| FREIS, ED | 1 |
| ACHOR, RW | 2 |
| HANSON, NO | 1 |
| GIFFORD, RW | 1 |
| KASS, I | 1 |
| BROWN, EC | 1 |
| LEREBOULLET, J | 1 |
| VIDART, L | 1 |
| AMSTUTZ, C | 1 |
| BURRELL, RH | 1 |
| MACKENZIE-VAN DER NOORDAA, MC | 1 |
| DUBOUCHER, G | 1 |
| LJUNGBERG, E | 2 |
| REISNER, H | 2 |
| FAUCETT, RL | 1 |
| LITIN, EM | 1 |
| GAHAGAN, LH | 1 |
| BARISON, F | 1 |
| MASSIGNAN, L | 1 |
| LANDGREBE, B | 1 |
| BUSSOW, H | 1 |
| LINDNER, W | 1 |
| WALTER, B | 1 |
| HOLZINGER, HH | 1 |
| SAUNDERS, JC | 1 |
| RADINGER, N | 1 |
| ROCHLIN, D | 1 |
| KLINE, NS | 2 |
| SIMKO, A | 1 |
| KROGSGAARD, AR | 1 |
| BARTLET, JE | 1 |
| JENSEN, K | 1 |
| ASSAEL, M | 1 |
| GABAY, F | 1 |
| KHAZAN, N | 1 |
| SULMAN, FG | 1 |
| WINNIK, HZ | 1 |
| FOUKS, L | 1 |
| MYSCHETZKY, A | 1 |
| RASMUSSEN, EB | 2 |
| HASLUND, J | 1 |
| STEIN, L | 1 |
| THOMAS, K | 1 |
| COULLAUT MENDIGUTIA, R | 1 |
| POELDINGER, W | 1 |
| NAHUNEK, K | 2 |
| BARTOVA, D | 1 |
| INGROVA, L | 1 |
| BOJANOVSKY, J | 1 |
| CHLOUPKOVA, K | 1 |
| RIPKA, O | 1 |
| PRANGE, AJ | 1 |
| KLEIN, JJ | 1 |
| SEGAL, RL | 1 |
| WARNER, RR | 1 |
| ROSENBERG, FJ | 1 |
| SAVARIE, PJ | 1 |
| FERGUSON, JT | 1 |
| DRAKE, FR | 1 |
| EBAUGH, FG | 1 |
| DAVIES, DL | 1 |
| SHEPHERD, M | 1 |
| KRISTJANSEN, P | 1 |
| RISER, M | 1 |
| GAYRAL, L | 1 |
| STERN, H | 1 |
| TURNIN, J | 1 |
| CARRIE, J | 1 |
| BACCHIOCHI, M | 1 |
| RODOVA, A | 1 |
| HOSAK, L | 1 |
| JAROS, M | 1 |
| HADLIK, J | 1 |
| Urigüen, L | 1 |
| Arteta, D | 1 |
| Díez-Alarcia, R | 1 |
| Ferrer-Alcón, M | 1 |
| Díaz, A | 1 |
| Pazos, A | 1 |
| Meana, JJ | 1 |
| Ghia, JE | 1 |
| Blennerhassett, P | 1 |
| Collins, SM | 1 |
| Stern, SL | 1 |
| Mendels, J | 1 |
| Johnson, JM | 1 |
| Leonard, BE | 1 |
| Swift, RM | 1 |
| Black, HR | 1 |
| Post, RM | 1 |
| Uhde, TW | 1 |
| Fielding, S | 1 |
| Szewczak, MR | 1 |
| Cooper, BR | 1 |
| Howard, JL | 1 |
| Soroko, FE | 1 |
| Willner, P | 1 |
| Moscovich, D | 1 |
| Mester, R | 1 |
| Zamoshchina, TA | 1 |
| Saratikov, AS | 1 |
| Mashkovskiĭ, MD | 1 |
| Andreeva, NI | 1 |
| Balldin, J | 1 |
| Granérus, AK | 1 |
| Lindstedt, G | 1 |
| Modigh, K | 1 |
| Wålinder, J | 1 |
| Lesch, KP | 1 |
| Gross, J | 1 |
| Wolozin, BL | 1 |
| Franzek, E | 1 |
| Bengel, D | 1 |
| Riederer, P | 1 |
| Murphy, DL | 1 |
| Patten, SB | 1 |
| Love, EJ | 1 |
| Applegate, WB | 1 |
| Pressel, S | 1 |
| Wittes, J | 1 |
| Luhr, J | 1 |
| Shekelle, RB | 1 |
| Camel, GH | 1 |
| Greenlick, MR | 1 |
| Hadley, E | 1 |
| Moye, L | 1 |
| Perry, HM | 1 |
| Healy, D | 2 |
| Savage, M | 1 |
| Ames, D | 1 |
| Einat, H | 1 |
| Belmaker, RH | 1 |
| Price, LH | 1 |
| Charney, DS | 1 |
| Heninger, GR | 1 |
| Fahn, S | 1 |
| Amsterdam, JD | 1 |
| Berwish, N | 1 |
| Widmer, RB | 1 |
| Vamvakidès, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Placebo Controlled Study of Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Parkinson's Disease[NCT00029666] | Phase 2 | 40 participants | Interventional | 2002-01-31 | Completed | ||
| [NCT00000514] | Phase 3 | 0 participants | Interventional | 1984-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for reserpine and Depression, Endogenous
| Article | Year |
|---|---|
Drug combinations in the treatment of refractory depression: a review.
Topics: Allopurinol; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Depressi | 1981 |
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; | 1984 |
Essential hypertension: psychiatric aspects and use of psychotropics.
Topics: Adrenergic beta-Antagonists; Analgesics; Anti-Anxiety Agents; Antidepressive Agents; Antihypertensiv | 1984 |
Pharmacology of nomifensine: a review of animal studies.
Topics: Acetylcholine; Adenylyl Cyclases; Aggression; Animals; Behavior, Animal; Brain Chemistry; Corpus Str | 1984 |
The validity of animal models of depression.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Behavior, Animal; Circadian Rhythm; Depressive Disorder; | 1984 |
Drug-induced depression. Incidence, avoidance and management.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Anabolic Agents; Benzodiazepines; Calcium Chan | 1994 |
The case for an individual approach to the treatment of depression.
Topics: Antidepressive Agents; Depressive Disorder; Emotions; Humans; Isoniazid; Personality; Receptors, Bio | 2000 |
[Animal models of psychiatric diseases: possibilities, limitations, examples and demonstration of use].
Topics: Animals; Antidepressive Agents; Depressive Disorder; Disease Models, Animal; Humans; Mental Disorder | 2001 |
4 trials available for reserpine and Depression, Endogenous
| Article | Year |
|---|---|
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; | 1984 |
Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Atenolol; Cerebrovascular Disorders; Chlorthali | 1994 |
Reserpine augmentation of desipramine in refractory depression: clinical and neurobiological effects.
Topics: Adult; Aged; Behavior; Blood Pressure; Body Temperature; Depressive Disorder; Desipramine; Drug Resi | 1987 |
Treatment of refractory depression with combination reserpine and tricyclic antidepressant therapy.
Topics: Adult; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Double-Blind | 1987 |
64 other studies available for reserpine and Depression, Endogenous
| Article | Year |
|---|---|
A standardization of the Novelty-Suppressed Feeding Test protocol in rats.
Topics: Animals; Antidepressive Agents; Depression; Depressive Disorder; Disease Models, Animal; Duloxetine | 2017 |
α- (phenylselanyl) acetophenone mitigates reserpine-induced pain-depression dyad: Behavioral, biochemical and molecular docking evidences.
Topics: Acetophenones; Analgesics; Animals; Antidepressive Agents; Antioxidants; Brain; Chronic Pain; Depres | 2018 |
Antidepressant-Like Effects of
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depression; Depressive Disorder; | 2018 |
Antidepressant-like effect of tetrahydroisoquinoline amines in the animal model of depressive disorder induced by repeated administration of a low dose of reserpine: behavioral and neurochemical studies in the rat.
Topics: Animals; Antidepressive Agents; Depressive Disorder; Disease Models, Animal; Dopamine; Hypothalamus; | 2014 |
Adenosine signaling in reserpine-induced depression in rats.
Topics: Adenosine; Adrenergic Uptake Inhibitors; Animals; Brain; Caffeine; Depressive Disorder; Dose-Respons | 2015 |
Echinocystic acid reduces reserpine-induced pain/depression dyad in mice.
Topics: Analgesics; Animals; Behavior, Animal; Brain; Depression; Depressive Disorder; Disease Models, Anima | 2016 |
Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia.
Topics: Adrenergic Uptake Inhibitors; Animals; Biogenic Amines; Central Nervous System; Depressive Disorder; | 2009 |
Mental depression in hypertensive patients treated for long periods with large doses of reserpine.
Topics: Depression; Depressive Disorder; Humans; Hypertension; Hypnotics and Sedatives; Rauwolfia; Reserpine | 1954 |
Hypertension treated with Rauwolfia serpentina (whole root) and with reserpine; controlled study disclosing occasional severe depression.
Topics: Antihypertensive Agents; Depressive Disorder; Depressive Disorder, Major; Disclosure; Hypertension; | 1955 |
Treatment of hypertensive patients with Rauwolfia compounds and reserpine; depressive and psychotic changes.
Topics: Antihypertensive Agents; Depression; Depressive Disorder; Humans; Hypertension; Psychoses, Substance | 1955 |
[Painful phantom limb with a depressive syndrome; spectacular cure with reserpine].
Topics: Antihypertensive Agents; Depression; Depressive Disorder; Phantom Limb; Reserpine; Secologanin Trypt | 1955 |
Reserpine depression treated with sodium succinate; a preliminary report.
Topics: Antihypertensive Agents; Central Nervous System Stimulants; Depression; Depressive Disorder; Humans; | 1955 |
[Depression after reserpine therapy of essential hypertension].
Topics: Antihypertensive Agents; Depression; Depressive Disorder; Essential Hypertension; Hypertension; Rese | 1956 |
[Depressive states with melancholia behavior during treatment of arterial hypertension with reserpine or Rauwolfia serpentina alkaloids].
Topics: Antihypertensive Agents; Depression; Depressive Disorder; Hypertension; Rauwolfia; Reserpine; Secolo | 1956 |
[Risks of depression with Rauwolfia management].
Topics: Alkaloids; Depression; Depressive Disorder; Disease Management; Humans; Rauwolfia; Reserpine; Risk | 1956 |
[Risks of depression with Rauwolfia management].
Topics: Alkaloids; Depression; Depressive Disorder; Disease Management; Humans; Rauwolfia; Reserpine; Risk | 1956 |
[Risks of depression with Rauwolfia management].
Topics: Alkaloids; Depression; Depressive Disorder; Disease Management; Humans; Rauwolfia; Reserpine; Risk | 1956 |
[Risks of depression with Rauwolfia management].
Topics: Alkaloids; Depression; Depressive Disorder; Disease Management; Humans; Rauwolfia; Reserpine; Risk | 1956 |
[Rauwolfia and depressive states].
Topics: Alkaloids; Depression; Depressive Disorder; Humans; Hypnotics and Sedatives; Rauwolfia; Reserpine | 1956 |
[Rauwolfia and depressive states].
Topics: Alkaloids; Depression; Depressive Disorder; Humans; Hypnotics and Sedatives; Rauwolfia; Reserpine | 1956 |
[Rauwolfia and depressive states].
Topics: Alkaloids; Depression; Depressive Disorder; Humans; Hypnotics and Sedatives; Rauwolfia; Reserpine | 1956 |
[Rauwolfia and depressive states].
Topics: Alkaloids; Depression; Depressive Disorder; Humans; Hypnotics and Sedatives; Rauwolfia; Reserpine | 1956 |
[Cases of administration of massive doses of reserpine].
Topics: Depression; Depressive Disorder; Reserpine | 1956 |
[Cases of administration of massive doses of reserpine].
Topics: Depression; Depressive Disorder; Reserpine | 1956 |
[Cases of administration of massive doses of reserpine].
Topics: Depression; Depressive Disorder; Reserpine | 1956 |
[Cases of administration of massive doses of reserpine].
Topics: Depression; Depressive Disorder; Reserpine | 1956 |
Neuropharmacologic action of Rauwolfia compounds and its psychodynamic implications.
Topics: Alkaloids; Depression; Depressive Disorder; Humans; Hypnotics and Sedatives; Rauwolfia; Reserpine | 1957 |
Ineffectiveness of chlorpromazine and Rauwolfia serpentina preparations in the treatment of depression.
Topics: Chlorpromazine; Depression; Depressive Disorder; Rauwolfia; Reserpine | 1957 |
[Observations on neurotic depressions with reference to a combined serpasil-ritalin treatment].
Topics: Combined Modality Therapy; Depression; Depressive Disorder; Manipulation, Osteopathic; Methylphenida | 1956 |
[Results of treatment with a new combination preparation in autonomic function disorders and depressive states].
Topics: Autonomic Nervous System; Autonomic Nervous System Diseases; Depression; Depressive Disorder; Ergot | 1957 |
[Inverse doriden effect in the course of a reserpine treatment of depressions].
Topics: Depression; Depressive Disorder; Glutethimide; Humans; Hypnotics and Sedatives; Reserpine | 1958 |
[Influencing of depressive states in geriatrics].
Topics: Aged; Depression; Depressive Disorder; Geriatrics; Methylphenidate; Reserpine | 1958 |
Treatment of depressed and regressed patients with iproniazid and reserpine.
Topics: Depression; Depressive Disorder; Iproniazid; Isomerism; Niacin; Nicotinic Acids; Reserpine | 1959 |
[Evaluation and management of depressive states appearing during reserpine therapy].
Topics: Depression; Depressive Disorder; Diphenhydramine; Disease Management; Humans; Reserpine | 1958 |
Side-effects of reserpine in the treatment of essential hypertension: with special reference to weight gain and mental depression.
Topics: Depression; Depressive Disorder; Essential Hypertension; Humans; Hypertension; Obesity; Reserpine; W | 1958 |
Place of methyl phenidate hydrochloride in psychiatric practice.
Topics: Depression; Depressive Disorder; Methylphenidate; Reserpine; Salts | 1959 |
Depressions in patients treated with reserpine for arterial hypertension.
Topics: Depression; Depressive Disorder; Humans; Hypertension; Reserpine | 1959 |
The mechanism of the combined treatment of depression with iproniazid and reserpine.
Topics: Combined Modality Therapy; Depression; Depressive Disorder; Iproniazid; Manipulation, Osteopathic; R | 1960 |
[The psychoanaleptic action of Disipal in the neuroleptic syndrome and in senile depression].
Topics: Aged; Aged, 80 and over; Aging; Antipsychotic Agents; Anxiety; Depression; Depressive Disorder; Huma | 1961 |
[Combined iproniazid-reserpine treatment-a placebo experiment].
Topics: Combined Modality Therapy; Depression; Depressive Disorder; Iproniazid; Manipulation, Osteopathic; R | 1960 |
Effects and interactions of imipramine, chlorpromazine, reserpine and amphetamine on self-stimulation: possible neurophysiological basis of depression.
Topics: Amphetamine; Amphetamines; Chlorpromazine; Depression; Depressive Disorder; Imipramine; Reserpine; S | 1961 |
[Suicide prevention with special reference to the pharmacopsychiatric treatment of depression].
Topics: Anti-Allergic Agents; Depression; Depressive Disorder; Histamine H1 Antagonists; Parasympatholytics; | 1962 |
[Endogenous depression and its treatment].
Topics: Antidepressive Agents; Depression; Depressive Disorder; Electroconvulsive Therapy; Humans; Imipramin | 1963 |
COMBINED ADMINISTRATION OF DESIPRAMINE AND RESERPINE OR TETRABENAZINE IN DEPRESSIVE PATIENTS.
Topics: Antidepressive Agents; Depression; Depressive Disorder; Desipramine; Humans; Imipramine; Reserpine; | 1963 |
[ON THE USE OF A COMBINATION OF RESERPINE AND TRIHEXYLPHENIDYL IN ENDOGENOUS DEPRESSIVE STATES].
Topics: Bipolar Disorder; Depressive Disorder; Humans; Mental Disorders; Psychotic Disorders; Reserpine; Tri | 1963 |
[TREATMENT OF ENDOGENOUS DEPRESSIONS WITH INTERMITTENT DOSES OF RESERPINE].
Topics: Depression; Depressive Disorder; Humans; Monoamine Oxidase Inhibitors; Paranoid Disorders; Reserpine | 1963 |
[HYPOTENSIVE AND SIDE-EFFECTS OF METHOXYPHENOSERPINE, A NEW RESERPINE DERIVATIVE].
Topics: Antihypertensive Agents; Anxiety; Depression; Depressive Disorder; Nasal Mucosa; Rauwolfia; Reserpin | 1963 |
THE PHARMACOLOGY AND BIOCHEMISTRY OF DEPRESSION.
Topics: Amitriptyline; Antidepressive Agents; Biochemical Phenomena; Biochemistry; Brain; Depression; Depres | 1964 |
GALACTORRHEA DUE TO IMIPRAMINE. REPORT OF A CASE.
Topics: Amenorrhea; Chlorpromazine; Depression; Depressive Disorder; Female; Galactorrhea; Humans; Hypothyro | 1964 |
THE PRACTICAL MANAGEMENT OF DEPRESSION.
Topics: Amitriptyline; Antidepressive Agents; Benzoates; Classification; Depression; Depressive Disorder; Dr | 1964 |
HISTAMINE AND THE REVERSAL OF CHLORPROMAZINE-INDUCED DEPRESSION.
Topics: Anti-Allergic Agents; Behavior, Animal; Chlorpromazine; Depression; Depressive Disorder; Histamine; | 1964 |
Treatment of reserpine-induced depression with a new analeptic: phenidylate.
Topics: Central Nervous System Stimulants; Depression; Depressive Disorder; Mental Disorders; Methylphenidat | 1955 |
The use of reserpine in office psychiatry: preliminary report.
Topics: Depression; Depressive Disorder; Mental Disorders; Psychiatry; Psychotherapy; Reserpine; Secologanin | 1955 |
Reserpine in the treatment of anxious and depressed patients.
Topics: Antihypertensive Agents; Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Reserpine; Sec | 1955 |
Iproniazid and combined iproniazid-reserpine treatment of depressive and inactive patients.
Topics: Combined Modality Therapy; Depression; Depressive Disorder; Iproniazid; Manipulation, Osteopathic; R | 1959 |
[Treatment of melancholic states with new chemotherapy agents: levomepromazine, imipramine, iproniazid, reserpine, deprol].
Topics: Antineoplastic Agents; Depression; Depressive Disorder; Imipramine; Iproniazid; Methotrimeprazine; P | 1959 |
[Nialamid and its combinations with reserpine-like substances (fenoharman, reserpine) in the therapy of endogenous depressions].
Topics: Depression; Depressive Disorder; Humans; Monoamine Oxidase Inhibitors; Reserpine | 1962 |
Gene expression patterns in brain cortex of three different animal models of depression.
Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Inflammatory Agents; Brain Chemistry; Cerebral Cortex; C | 2008 |
Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression.
Topics: Animals; Antidepressive Agents; Brain; Colitis; Depressive Disorder; Disease Models, Animal; Female; | 2008 |
Pharmacology of new antidepressants.
Topics: Animals; Antidepressive Agents; Brain; Depressive Disorder; Disease Models, Animal; Dopamine; Humans | 1984 |
Biological relationships between mania and melancholia.
Topics: Affective Disorders, Psychotic; Antidepressive Agents, Tricyclic; Bipolar Disorder; Carbamazepine; D | 1982 |
Animal models used in prediction of antidepressant effects in man.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Depressive Disorder; Drug Evaluation, P | 1983 |
Tricyclic antidepressive treatment reinforced by reserpine.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Therapy, Combination; Femal | 1984 |
[Electroencephalographic characteristics of "reserpine depression" (experimental study)].
Topics: Amygdala; Animals; Caudate Nucleus; Cerebral Cortex; Depressive Disorder; Disease Models, Animal; El | 1984 |
alpha-Methyldopa and depression.
Topics: Depressive Disorder; Drug Therapy, Combination; Humans; Hypertension; Methyldopa; Reserpine | 1984 |
[Experimental and clinical characteristics of the Soviet antidepressant inkasan].
Topics: Amphetamine; Animals; Antidepressive Agents; Apomorphine; Biogenic Amines; Brain; Carbolines; Cats; | 1984 |
Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy.
Topics: Adult; Aged; Apomorphine; Clonidine; Depressive Disorder; Electroconvulsive Therapy; Female; Growth | 1982 |
Direct sequencing of the reserpine-sensitive vesicular monamine transporter complementary DNA in unipolar depression and manic depressive illness.
Topics: Adult; Aged; Base Sequence; Bipolar Disorder; Blood Platelets; Depressive Disorder; DNA, Complementa | 1994 |
Reserpine exhumed.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Depressive Disorder; Humans; Reserpine; Risk Assessme | 1998 |
Reserpine exhumed.
Topics: Antipsychotic Agents; Clinical Competence; Depressive Disorder; Humans; Physicians; Reserpine | 1998 |
A therapeutic approach to tardive dyskinesia.
Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Colitis; Depressive Disorder; Dyskinesia | 1985 |
Reserpine: the maligned antihypertensive drug.
Topics: Antihypertensive Agents; Breast Neoplasms; Depression; Depressive Disorder; Humans; Hypertension; Re | 1985 |
[2 new GABA-ergics (GABA-linoleamide and GABA-steatamide). On 2 experimental models of depression].
Topics: Animals; Apomorphine; Catalepsy; Depressive Disorder; Drug Synergism; gamma-Aminobutyric Acid; Human | 1985 |